A study shows T1a RCC patients have improved overall survival when receiving partial nephrectomy compared with radical nephrectomy.
A radiographic measure may help clinicians distinguish between benign renal oncocytoma and chromophobe renal cell carcinoma.
Patients with von Hippel-Lindau disease may have a new treatment option in the antiangiogenic therapy pazopanib.
A study shows hyperprogressive disease (HPD) occurred more commonly among patients with pretreated non-small cell lung cancer (NSCLC) receiving PD-1/PD-L1 inhibitors.
A study shows expanding access to care through insurance has the potential to improve outcomes in adults with follicular lymphoma.
Survivors of oropharyngeal cancers who developed late lower cranial neuropathy reported having worse treatment-related symptoms.
Antiretroviral therapy and rituximab show promise in aids-related diffuse large B-cell lymphoma patients.
A study shows pretreatment ctDNA levels and molecular responses are independently prognostic of outcomes in lymphomas.
The PVX-410 vaccine shows immune responses in a patient population with smoldering myeloma.
A study shows prescription drug coverage leads to better survival among Medicare beneficiaries with multiple myeloma.